REVIMMUNE Trademark

Trademark Overview

On Monday, November 19, 2018, a trademark application was filed for REVIMMUNE with the United States Patent and Trademark Office. The USPTO has given the REVIMMUNE trademark a serial number of 88198822. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by RevImmune, Inc.. The REVIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Biological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders
revimmune

General Information

Serial Number88198822
Word MarkREVIMMUNE
Filing DateMonday, November 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesBiological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRevImmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814
Party NameRevImmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 9, 2021CORRECTED NOA E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 5 GRANTED
Wednesday, November 24, 2021SOU EXTENSION 5 FILED
Wednesday, December 8, 2021DIVISIONAL PROCESSING COMPLETE
Monday, November 29, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, December 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 29, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, November 24, 2021TEAS EXTENSION RECEIVED
Thursday, May 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 25, 2021SOU EXTENSION 4 GRANTED
Tuesday, May 25, 2021SOU EXTENSION 4 FILED
Tuesday, May 25, 2021TEAS EXTENSION RECEIVED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020SOU EXTENSION 3 GRANTED
Tuesday, November 24, 2020SOU EXTENSION 3 FILED
Tuesday, November 24, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020SOU EXTENSION 2 GRANTED
Friday, May 29, 2020SOU EXTENSION 2 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Wednesday, November 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019SOU EXTENSION 1 GRANTED
Monday, November 18, 2019SOU EXTENSION 1 FILED
Monday, November 18, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 22, 2019ASSIGNED TO EXAMINER
Thursday, December 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 22, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

revimmune treatment biological diseases pharmaceutical preparations immune modulation system disorders related